 WIXOM, Mich., April 22, 2021 GLOBE NEWSWIRE -- Rockwell Medical, Inc. Nasdaq: RMTI, a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it presented data from a clinical feasibility study reviewing the practice patterns of iron deficiency anemia IDA in home parenteral nutrition patients at the National Home Infusion Associations NHIA 2021 Annual Conference, taking place virtually from April 19 to 22, 2021. 